iCAD Inc. Company Profile

News Articles [ 32 Associated News Articles listed on BioPortfolio]

Invivo and iCAD Collaborate to Provide MRI Technology Worldwide

Invivo, a Philips Healthcare business and a developer of MRI systems, and iCAD, a provider of imaging and radiation...

ICAD's brachytherapy system wins FDA nod

Nashua, N.H.-based iCAD has received FDA clearance for its Xoft Axxent system for electronic brachytherapy, designed for targ -More- 

CMS raises reimbursement rate for iCad's brachytherapy device

The CMS has agreed to increase the reimbursement rate for intraoperative radiation therapy procedures that use iCad's Xoft Ax -More- 

Next-gen digital mammo platform from iCAD wins FDA nod

The FDA has given iCAD approval for its PowerLook advanced mammography platform, which comes with capabilities for digital co -More- 

iCAD Debuts Powerlook Advanced Mammography Platform And New Version Of MRI Suite For First Time At RSNA

iCAD, Inc. showcased its family of CAD and advanced imaging solutions at the Radiological Society of North America's (RSNA) Annual Meeting, November 25-30, 2012 in Chicago, Ill. iCAD offers a compreh...

Chindex, Medvio to distribute iCAD isotope-free radiation therapy device

Chindex Medical and Medvio have entered into a collaboration agreement with an advanced imaging and radiation therapy technologies provider iCAD.

iCAD financial update

iCAD to Present at the 12th Annual Needham Healthcare Conference

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of c...

Drugs and Medications [0 Results]

None

PubMed Articles [ 7 Associated PubMed Articles listed on BioPortfolio]

Differential features of carotid and vertebral artery dissections: The CADISP Study.

OBJECTIVE: To examine whether risk factor profile, baseline features, and outcome of cervical artery dissection (CEAD) differ according to the dissection site. METHODS: We analyzed 982 consecutive pat...

Detection of slime and methicillin resistance genes in Staphylococci isolated from nasal samples of patients with orthopaedic implants.

Background: The purposes of the present study were (1) to determine the prevalence of mecA and femA genes, (2) to investigate the presence of icaA and icaD genes responsible for slime synthesis, and (...

Prevention of Intracranial In-stent Restenoses: Predilatation with a Drug Eluting Balloon, Followed by the Deployment of a Self-Expanding Stent.

PURPOSE: Stenting in intracranial atherosclerotic disease (ICAD) is increasingly debated, due to issues of procedural safety, technical efficacy, and in-stent recurrent stenoses (ISR). In the present...

Treatment of Intracranial Atherosclerotic Disease with a Balloon-Expandable Paclitaxel Eluting Stent : Procedural Safety, Efficacy and Mid-Term Patency.

PURPOSE: Procedural safety and high rates of in-stent recurrent stenotic lesions (ISR) remain a concern in the endovascular treatment of intracranial atherosclerotic disease (ICA...

Functional outcome in young adult ischemic stroke: impact of lipoproteins.

AIM: To determine the functional outcome in a cohort of young adults with ischemic stroke patients, focusing on components of lipid profile. METHODS: In our registry including consecutive patients wit...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

iCAD Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing ca...

iCAD, Inc.

iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologi...